🔎 Trials Near Me

홈 › 유방암 › 코네티컷

코네티컷의 유방암 임상 시험

유방암 관련 연구 50개가 코네티컷 내 여러 지역에서 참여자를 모집하고 있습니다.

코네티컷의 도시

공식 연구 텍스트(영어)

Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors

  • Yale University - Yale University School of Medicine, New Haven
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 13. 업데이트됨 · NCT07360314

An Investigational Study of BG-75202 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors

  • Yale Cancer Center, New Haven
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT07222267

A Study Evaluating Adherence, Tolerability, and Patient Reported Outcomes of Giredestrant in Participants With ER+/HER2- Early Breast Cancer Who Are Intolerant to Adjuvant Aromatase Inhibitor Therapy (novERA Breast Cancer)

  • Eastern CT Hematology and Oncology Associates, Norwich
피험자 모집 중3상
18세 이상 · 여성 · 2026. 11. 12. 업데이트됨 · NCT07541079

Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

  • Smilow Cancer Hospital - Yale New Haven Health, New Haven
  • Yale-New Haven Hospital-Yale Cancer Center, New Haven
  • Smilow Cancer Hospital Phase 1 Unit, New Haven
  • 외 2개
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT04557449

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

  • Yale Cancer Center, New Haven
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT07029399

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

  • Yale University School of Medicine, New Haven
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT06324357

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

  • Hartford Healthcare Institute, Hartford
  • Yale Cancer Center, New Haven
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT07214532

Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration

  • Yale Cancer Center, New Haven
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT05315700

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

  • Yale-New Haven Hospital-Yale Cancer Center, New Haven
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT06982521

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

  • UConn Health, Farmington
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07174336

E-Mindfulness Approaches for Living After Breast Cancer

  • Stamford Hospital/Bennett Cancer Center, Stamford
피험자 모집 중3상
18세 ~ 50세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06748222

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Veterans Affairs Connecticut Healthcare System-West Haven Campus, West Haven
피험자 모집 중관찰 연구건강한 지원자 환영
40세 ~ 75세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT05334069

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

  • Hartford HealthCare - Avon, Avon
  • Hartford HealthCare - Saint Vincent's Medical Center, Bridgeport
  • Danbury Hospital, Danbury
  • 외 19개
피험자 모집 중3상
18세 ~ 60세 · 여성 · 2026. 11. 4. 업데이트됨 · NCT05879926

A Study of JNJ-101684362 (HLD-0117) in Patients With Metastatic Breast Cancer

  • Yale University School Of Medicine, New Haven
피험자 모집 중1상
18세 이상 · 여성 · 2026. 11. 3. 업데이트됨 · NCT07524855

A Phase 1 Study of IM-1617 in Participants With Advanced Cancer

  • Yale Cancer Center, New Haven
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT07578571

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

  • Smilow Cancer Hospital Care Center - Derby, Derby
  • Smilow Cancer Hospital Care Center - Fairfield, Fairfield
  • Smilow Cancer Hospital at Glastonbury, Glastonbury
  • 외 10개
피험자 모집 중3상
60세 이상 · 모든 성별 · 2026. 11. 2. 업데이트됨 · NCT06377852

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

  • Yale Cancer Center, New Haven
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 10. 26. 업데이트됨 · NCT06172478

The Cancer of the Pancreas Screening-5 CAPS5)Study

  • Yale University, New Haven
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 10. 22. 업데이트됨 · NCT02000089

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

  • Smilow Cancer Hospital - Derby, Derby
  • Smilow Cancer Hospital - Fairfield, Fairfield
  • Smilow Cancer Hospital - Glastonbury, Glastonbury
  • 외 11개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 10. 19. 업데이트됨 · NCT07062965

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

  • Stamford Hospital ( Site 0049), Stamford
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 10. 13. 업데이트됨 · NCT06312176

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

  • Yale University, Yale Cancer Center, New Haven
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 13. 업데이트됨 · NCT06993844

DAANCE FOR CHEMOTHERAPY-INDUCED NEUROPATHY

  • Yale University, New Haven
피험자 모집 중2상
40세 이상 · 모든 성별 · 2026. 10. 9. 업데이트됨 · NCT06749210

A Study of PHST001 in Advanced Solid Tumors

  • Yale Cancer Center, New Haven
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 5. 업데이트됨 · NCT06840886

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • Yale Cancer Center, New Haven
피험자 모집 중1/2상
12세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT04585750

A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer

  • Yale University School of Medicine - Yale Cancer Center, New Haven
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT07701941

Study of AVZO-021 in Patients With Advanced Solid Tumors

  • Avenzo Therapeutics Recruiting Site, New Haven
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT05867251

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

  • Research Site, New Haven
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06103864

A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

  • Kivu Trial Site, New Have
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT07229313

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

  • Clinical Trial Site, New Haven
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07085767

Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer

  • Norwalk Hospital, Norwalk
피험자 모집 중2상
45세 이상 · 여성 · 2026. 9. 21. 업데이트됨 · NCT04084730

Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies

  • Yale Cancer Center Clinical Trials Office, New Haven
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT07340541

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

  • Smilow Cancer Hospital at Yale New Haven, New Haven
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT06072612

TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd

  • Yale University Cancer Center, New Haven
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 8. 26. 업데이트됨 · NCT06533826

Optimizing Surgical Decisions in Young Adults With Breast Cancer

  • Yale Cancer Center, New Haven
피험자 모집 중
18세 ~ 44세 · 여성 · 2026. 8. 19. 업데이트됨 · NCT06275126

ATEMPT 2.0: Adjuvant T-DM1 vs TH

  • Smilow Cancer Hospital Care center at Derby, Derby
  • Smilow Cancer Hospital Care center at Fairfield, Fairfield
  • Smilow Cancer Hospital Care center at Glastonbury, Glastonbury
  • 외 11개
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 8. 19. 업데이트됨 · NCT04893109

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

  • Yale Cancer Center - Smilow Cancer Hospital, New Haven
피험자 모집 중3상
18세 ~ 100세 · 모든 성별 · 2026. 8. 6. 업데이트됨 · NCT05232916

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

  • Norwalk Hospital, Norwalk
피험자 모집 중2상
8세 이상 · 모든 성별 · 2026. 7. 27. 업데이트됨 · NCT05503797

Pre-Operative Window of ET to Inform RT Decisions (POWER II)

  • Yale University, New Haven
피험자 모집 중3상
65세 이상 · 여성 · 2026. 6. 30. 업데이트됨 · NCT06507618

Integrated Cancer Repository for Cancer Research

  • Hartford HealthCare Cancer Institute at Manchester Medical Hospital, Manchester
피험자 모집 중관찰 연구건강한 지원자 환영
19세 ~ 110세 · 모든 성별 · 2026. 6. 29. 업데이트됨 · NCT02012699

Efficacy of Trastuzumab Deruxtecan in Metastatic Breast Cancer With Different HER2 Expression Patterns

  • Yale Cancer Center, New Haven
피험자 모집 중관찰 연구
18세 ~ 80세 · 여성 · 2026. 5. 22. 업데이트됨 · NCT06551220

ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.